中国医药研究市场报告

1、ibisworld and acmr china industry report 05 august 2010 medical research in china: 7540 disclaimer this product has been supplied by ibisworld inc. (ibisworld) solely for use by its authorized licenses strictly in accordance with their license agreements with ibisworld. ibisworld and all china marke

2、ting research co., ltd. (acmr) makes no representation to any person with regard to the completeness or accuracy of the data or information contained herein, and it accepts no responsibility and disclaims all liability (save for liability which cannot be lawfully disclaimed) for loss or damage whats

3、oever suffered or incurred by any other person resulting from the use of, or reliance upon, the data or information contained herein. copyright in this publication is owned by ibisworld inc. and all china marketing research co., ltd. (acmr). the publication is sold on the basis that the purchaser ag

4、rees not to copy the material contained within it for other than the purchasers own purposes. in the event that the purchaser uses or quotes from the material in this publication - in papers, reports, or opinions prepared for any other person - it is agreed that it will be sourced to ibisworld inc.

5、contents industry definition. 3 activities (products and services) .3 similar industries .3 demand and (2) non-enterprise medical research institutions. there are expected to be 9,060 establishments operating within the industry during 2010, employing about 95,600 people with an estimated payroll of

6、 $721.5 million. many foreign pharmaceutical companies have outsourced their research projects to contract research organizations (cro) in china. this is due to the abundant supply of laboratory animals, lower labor costs and relatively lighter regulations on biological and medical research in china

7、 compared to developed countries. the following research functions are not included in this industry: (1) research and development activities conducted by enterprises in the pharmaceutical or medical equipment manufacturing industries; (2) biological research unrelated to the human body or human dis

8、eases; (3) veterinary medical research; and, (4) the commercialization of medical or pharmaceutical research. linkages demand linkages 2720 - pharmaceutical and medicine manufacturing in china establishments in this industry are primarily engaged in manufacturing chemical medicinal and pharmaceutica

9、l products in various formats, including ampoules, tablets, capsules, vials, ointments, powders, solutions, suspensions and radioactive medicine. 2740 - chinese patent drug manufacturing in china establishments in this industry are primarily engaged in manufacturing patent traditional chinese medici

10、ne products in various formats, including ampoules, tablets, capsules, ointments, powders, solutions and suspensions. 3681 - medical diagnosis, monitoring and treatment equipment manufacturing in china establishments in this industry are mainly engaged in manufacturing medical diagnosis equipment, m

11、edical monitoring equipment and medical treatment equipment. 7710 - technical popularization in china establishments in this industry provide services to popularize and commercialize the achievements of scientific research, including medical research. copyright 2010, ibisworld inc., all china market

12、ing research co., ltd. 14 market characteristics medical research in china 05 august 2010 8511 - general hospitals in china this industry comprises establishments known and licensed as general hospitals primarily engaged in providing diagnostic and medical treatment (both surgical and non-surgical)

13、to inpatients and outpatients treating a wide variety of medical conditions. 8512 - traditional chinese medicine hospitals in china hospitals in this industry provide diagnostic and medical treatment to patients according to the theories and practices of traditional chinese medicine. supply linkages

14、 2662 - special chemical products manufacturing in china establishments in this industry are engaged in manufacturing special chemical products used in biological engineering, medical research, water pollution, paper making and other specialized fields. 2760 - biological and biochemical product manu

15、facturing in china establishments in this industry are engaged in manufacturing biochemical drugs and genetic engineering drugs through biotechnologies. they provide diagnostic reagents, enzymes and cell products for medical laboratories. 3144 - glass instruments manufacturing in china establishment

16、s in this industry are engaged in manufacturing glass instruments used by various laboratories and medical practices. 3683 - laboratory and disinfectant equipment and utensils manufacturing in china establishments in this industry are engaged in manufacturing equipment and utensils used for disinfec

17、tion and sterilization in laboratories or medical practices. 7720 - technical intermediation in china establishments in this industry provide services such as scientific information, scientific consultation, research project bidding, etc, for medical research units. demand determinants the major dem

18、and determinants for services provided by the medical research industry in china include government policies, medical research commercialization, medical research costs, resource availability, and practical applications for medical clinics. government policies and funding the majority of chinas medi

19、cal research funding is from the government. government policies affect the total level of government assistance toward medical research, the allocation of funding, other government incentives for medical research and the commercialization of relevant research outcomes. government incentives include

20、 tax concessions and grants for medical research and development activities. commercialization of medical research results medical research that can be easily commercialized and lead to large or quick returns are more easily able to obtain funding from the government or the private sector, such as p

21、harmaceutical companies or medical equipment copyright 2010, ibisworld inc., all china marketing research co., ltd. 15 market characteristics medical research in china 05 august 2010 manufacturers. also, companies and other organizations will carry out medical research if they can easily and cheaply

22、 patent the technology, as the intellectual property can further increase revenue through transference or licensing. medical research costs industry revenue is mainly sourced from government funding, and therefore is less dependent on medical research costs. however, there is a growing reliance on f

23、unding from the private sector, which is concerned with the commercial viability of research. high cost studies with minimal promise of returns can limit the demand for services. resources and technology availability medical research is more likely to be in demand if appropriate labor skills, materi

24、als, processes and capital are available for laboratories. access to these factors can ensure the steady progress of research activities. also, technological advances involving microelectronics, bio chips, genomics and bio materials allow for the development of new products that increase the capabil

25、ities and quality of medical research. practical applications for clinical practices medical research results or outcomes need to be directly or indirectly useful in clinical practice. new trends in clinical treatment of diseases will guide the project selection of medical research. therefore, the i

26、ntegration between medical research and clinical practices can promote hospital demand for medical research. domestic and international markets domestic and international markets exports the level of trade export is low the trend of trade export is steady domestic and international markets imports t

27、he level of trade import is low the trend of trade import is steady domestic and international markets analysis there is no export or import activity involved in this industry. basis of competition competition in this industry is medium competition in this industry is increasing external competition

28、 external competition for this industry is mainly from the research and development departments of pharmaceutical companies and hospitals. there is a growing partnership trend between these establishments. pharmaceutical companies copyright 2010, ibisworld inc., all china marketing research co., ltd

29、. 16 market characteristics medical research in china 05 august 2010 now more likely to invest in medical research institutions, or outsource some research projects to establishments in this industry. internal competition industry institutions can be divided into two categories: biotechnology compan

30、ies and non-enterprise medical research institutions. biotechnology companies, including many cros (contract research organization), usually target niche research markets. they provide test, experiment or consultation services for other research units. therefore, they compete for contracts from othe

31、r research units or downstream industries such as pharmaceuticals manufacturing. non-enterprise medical research institutions are generally focused on the research activity itself, for which funding is vital. therefore, they compete for funding and grants from both public and private sectors. compet

32、ition between establishments is based on: innovation and professionals medical research is an innovative activity, which requires the contribution of professional researchers and the use of advanced technologies. the reputation of research facilities, and that of key researchers, is a major advantag

33、e in the market place. there is significant domestic and international competition to attract world renowned researchers. an organization that owns proprietary technology, or has access to advanced technology appropriate to medical research, will have a competitive advantage. budget superior financi

34、al resources allow entities to: (1) operate and manage large-scale medical research projects; (2) utilize advanced equipment and technologies, as well as high-quality materials, for research; (3) employ the best researchers in specific research fields; (4) deploy and integrate high-specification inf

35、ormation technology systems; and, (5) build and maintain a full range of databases. government relationshipsbgh as the funding for medical research in china is mainly from the government, good relationships with government administrations are extremely important for medical research institutions. al

36、though the distribution channels of research funding in china have adopted standard expert reviewing mechanisms, many reviewers still tend to grant funds to those who have close relationship with them. this is mainly due to the lack of external supervision for the reviewers. research quality for non

37、-enterprise medical research institutions, research quality can be measured by the number of papers published in major research magazines, and the influential factors of the papers. copyright 2010, ibisworld inc., all china marketing research co., ltd. 17 market characteristics medical research in c

38、hina 05 august 2010 high research quality will help an institution to apply for new funding from the government, and are more likely to attract investment from the private sector such as pharmaceutical manufacturers. patent protection research institutions that can patent their research in a timely

39、manner and successfully protect the patents are then able license the patents to enterprises in the pharmaceutical or medical equipment manufacturing industries, which increases their income. range of research fields large medical research institutes tend to have laboratories equipped to cover a ran

40、ge of medical disciplines. with the development of interdisciplinary research, this will bring competitive advantages to the large institutes. specialization some smaller research institutions are specializing in niche medical or pharmaceutical fields. biotechnology companies tend to provide service

41、s in specialized research fields, such as clinical trials. long-time experience in a specific research field usually brings competitive advantages to the research institutions. life cycle life cycle stage the life cycle stage is growth life cycle reasons funding from the central government and local

42、 governments has increased substantially in recent years more pharmaceutical companies, medical equipment manufacturers and hospitals entrust research and development activities to research institutions in this industry more professional chinese medical and pharmaceutical researchers have returned f

43、rom foreign countries to china the development of scientific and technological agents will promote the development of research achievements, and hence the industrys development life cycle analysis total expenditure on research and development has increased substantially in china, from $10.8 billion

44、in 2000 to $66.91 billion in 2009. the ratio of r (2) the government encourages the development of new technologies, new products and new materials; (3) the government encourages collaboration between enterprises and research institutions or universities for research and development activities; (4)

45、the government ensures a proper share of funding for basic research and applied research in the total expenditure for research and development; (5) the government establishes foundations for natural sciences to fund basic research and applied research; (6) the government encourages research institut

46、ions to co-operate with enterprises for commercialization of research results; (7) the government encourages research institutions to restructure into enterprises or to provide payable services; (8) research and development institutions can collect funding through various channels from the private s

47、ector; (9) domestic research institutions can establish branches or make investment in foreign countries; (10) foreign organizations or individuals can establish wholly-owned or joint-venture research and development institutions in china. patent law of the peoples republic of china this law was pro

48、mulgated in march 1984 and revised in september 1992. the laws main points include: (1) for research conducted using equipment and materials supplied by a research institution, where the researcher is employed, the patent right belongs to the institution. for research conducted by the researcher, wi

49、thout the use of equipment or materials belonging to the institution, the patent right belongs to the researcher. copyright 2010, ibisworld inc., all china marketing research co., ltd. 23 industry conditions medical research in china 05 august 2010 (2) two or more applicants applying for patent righ

50、t of the same research the patent right will belong to the applicant who applies first. (3) the patent right can be transferred. the transference of patent right from domestic institution or individuals to foreign institutions or individuals should be approved by relevant administrations under state

51、 council of china. (4) the validity period for a patent of creation in china is 20 years. for a design patent, the period is 10 years. copyright law of the peoples republic of china this law was promulgated in september 1990 and took effect from june 1991. the law applies to the literature, design d

52、rawings, audiovisual products and software originating from scientific research and development activities. copyright is protected by the government and plagiarism is forbidden. law of the peoples republic of china on promoting the transformation of scientific and technological achievements this law

53、 was promulgated in may 1996 and implemented from october 1996. main points of the law include: (1) relevant government administrations can conduct public bidding for the transformation of key scientific or technological research achievements; (2) proprietors of scientific or technological research

54、achievements can invest on their own to transform the findings, or transfer the research to others. they can also take the achievements as investments or shares to jointly transform the achievements with others; (3) in the transformation activity, the research institutions, research achievement tran

55、sforming institutions and the investors should sign contracts concerning the subsequent application and operation of the achievements; (4) the government ensures a certain share among the total funding for research and development to be used in the transformation of research results; (5) the governm

56、ent provides favorable taxation polices for transformation of scientific and technological achievements. circular on the inspection of medical research institutions operating medical practices this circular was jointly issued by ministry of health and ministry of science and technology in 2005. it w

57、as aimed to identify, inspect and close down the illegal medical practices conducted by medical research institutions without the practice license of medical institutions. local regulations although there is no national regulation concerning the application and implementation of medical research pro

58、jects, there are several regulations issued by the provincial government for medical research projects. examples include measures for administration of medical research projects of beijing city, which was promulgated in 2001, and the measures for administration of medical research projects of shaanx

59、i province, which took effect from january 2008. copyright 2010, ibisworld inc., all china marketing research co., ltd. 24 industry conditions medical research in china 05 august 2010 cost structure year: 2010 item purchases wages depreciation tax and interest rent utilities other profit cost % 43.5

60、%* 14.4%* 7.5%* 3.3%* 3.0%* 1.0%* 26.5%* 0.8%* this industry had negative profitability in 2008 of 3.3%, but is forecast to return a small profit of 0.8% in 2010. this low profit was the result of high costs for medical research and commercialization difficulties to recoup expenditures. profitabilit